跳至主要内容
临床试验/NCT07538284
NCT07538284尚未招募2 期

Minimizing Delirium With Nasal Dexmedetomidine-Induced Sleep in Older Patients Undergoing Major Abdominal Surgery: : a Randomized, Double-blind, Placebo-controlled Trial

Sixth Affiliated Hospital, Sun Yat-sen University0 个研究点目标入组 400 人开始时间: 2026年5月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
400
主要终点
Incidence of postoperative delirium

研究概览

简要总结

This study aims to determine whether, compared with placebo, the nighttime self-administration of a nasal dexmedetomidine is effective at inducing sleep and preventing postoperative delirium in high-risk patients.

详细描述

Delirium is an acute, short-term brain dysfunction characterized by fluctuating consciousness, cognitive decline, inattention, and sleep-wake cycle disruption. Postoperative delirium (POD), occurring predominantly within the first postoperative week (especially days 3-5 in elderly patients), affects 11-45% of older adults after major surgery. POD prolongs hospitalization, increases morbidity and mortality 5,65,6, yet its pathophysiology remains unclear, and evidence-based pharmacological prevention is lacking. Thus, effective POD prevention strategies are urgently needed.

Preoperative anxiety, a modifiable risk factor for POD, affects 11-80% of surgical patients. It contributes to sleep disturbances (e.g., insomnia, early awakening), which may exacerbate POD via neuroendocrine and immune dysregulation. However, benzodiazepines (e.g., lorazepam, diazepam, midazolam), though effective anxiolytics, increase delirium risk and are contraindicated preoperatively per current guidelines.

Dexmedetomidine (DEX), a selective α2-adrenoceptor agonist, induces physiological non-REM sleep without respiratory depression or hemodynamic instability. Its nasal formulation offers high bioavailability (82%), ease of administration, and is approved in China for preoperative sedation/anxiety. While intravenous (IV) DEX reduces POD in predominant ICU settings, its use in general wards remains unexplored. Preclinical studies suggest DEX enhances glymphatic clearance and exerts anti-inflammatory effects, potentially mitigating the development of POD. This study thus hypothesize that a nasal dexmedetomidine is effective at inducing sleep and preventing postoperative delirium in high-risk patient population. We set to demonstrate that to determine whether, compared with placebo, the nighttime self-administration of a nasal dexmedetomidine is effective at inducing sleep and preventing postoperative delirium in older patients undergoing major abdominal surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
65 Years 至 90 Years(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 65-90 years
  • Scheduled for a major abdominal surgery with estimated surgery time ≥ 2 hours

排除标准

  • Blind, deafness or the inability to speak mandarin
  • Allergy to dexmedetomidine.
  • Renal and liver failure requiring dialysis or Child-Pugh score > 5
  • Follow-up difficulties (i.e. active substance abuse, psychotic disorder, homelessness)
  • Previous major abdominal or cardiac surgery within 1 year of surgical procedure
  • Chronic therapy with benzodiazepines and/or antipsychotics. Severe deficit due to structural or anoxic brain damage
  • Body weight < 35 kg

研究组 & 干预措施

Placebo

Placebo Comparator

干预措施: Placebo (Drug)

Dexmedetomidine

Experimental

干预措施: Dexmedetomidine (Drug)

结局指标

主要结局

Incidence of postoperative delirium

时间窗: Up to postoperative day (POD) 7 or discharge (whichever first).

Confusion Assessment Method

次要结局

  • Delirium severity(Up to postoperative day (POD) 7 or discharge (whichever first))
  • Physical activity(Up to postoperative day (POD) 3)
  • Sleep quality(Up to postoperative day (POD) 3)
  • Anxiety(Up to postoperative day (POD) 3)
  • Pain intensity(Up to postoperative day (POD) 3)
  • Opioid consumption(Up to postoperative day (POD) 3)
  • Health related quality of life(On postoperative day (POD) 3 and 30)
  • Quality of Recovery(Up to postoperative day (POD) 3)
  • Postoperative Nausea and Vomiting(Up to postoperative day (POD) 3)
  • Post-anesthesia Care Unit (PACU) length of stay(Up to postoperative day (POD) 1)

研究者

发起方
Sixth Affiliated Hospital, Sun Yat-sen University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Xiangcai Ruan, MD, PhD

Professor

Sixth Affiliated Hospital, Sun Yat-sen University

相似试验